Literature DB >> 19394664

Evaluation of directly observed therapy for tuberculosis in KwaZulu-Natal, South Africa.

Sbongile P Ntshanga1, Roxana Rustomjee, Musawenkosi L H Mabaso.   

Abstract

Tuberculosis (TB) is one of the leading causes of morbidity and mortality in KwaZulu-Natal (KZN), South Africa. Directly observed therapy (DOT) is a key element of the WHO's Directly Observed Treatment, Short Course (DOTS) strategy to control TB. Since the inception of DOTS in South Africa in 1996, its impact has never been assessed. We evaluated the DOT programme in the priority facilities of the four TB crises districts (EThekwini, UMgungundlovu, UMzinyathi and UThungulu) in the province of KwaZulu-Natal. A semi-structured questionnaire was used to interview TB nurses and community DOT supporters. The primary outcome used was cure rate. On average, priority facilities in districts that have high DOT coverage had better cure rates compared with those that have low DOT coverage (beta=0.818, 95% CI 0.023-1.614; P=0.045). The fewer the number of patients allocated to a DOT supporter the higher the cure rates (beta=-1.984; 95% CI -3.88 to 0.086; P=0.041). There was no difference in cure rates between facilities with tangible reporting and recording methods and those with none. These findings suggest that cure rates can be improved if DOT is implemented appropriately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394664     DOI: 10.1016/j.trstmh.2009.03.021

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa.

Authors:  Julia V Ershova; Laura Jean Podewils; Liza E Bronner; Heather G Stockwell; Sicelo S Dlamini; Lerole D Mametja
Journal:  S Afr Med J       Date:  2014-03-26

2.  The relationship between (stigmatizing) views and lay public preferences regarding tuberculosis treatment in the Eastern Cape, South Africa.

Authors:  Jane M Cramm; Anna P Nieboer
Journal:  Int J Equity Health       Date:  2011-01-14

3.  Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study.

Authors:  Alyssa Finlay; Joey Lancaster; Timothy H Holtz; Karin Weyer; Abe Miranda; Martie van der Walt
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

4.  Listening to Those at the Frontline: Patient and Healthcare Personnel Perspectives on Tuberculosis Treatment Barriers and Facilitators in High TB Burden Regions of Argentina.

Authors:  Sarah J Iribarren; Fernando Rubinstein; Vilda Discacciati; Patricia F Pearce
Journal:  Tuberc Res Treat       Date:  2014-09-28

5.  Tuberculosis in Brazil: last ten years analysis - 2001-2010.

Authors:  Gisele Pinto de Oliveira; Ana Wieczorek Torrens; Patrícia Bartholomay; Draurio Barreira
Journal:  Braz J Infect Dis       Date:  2013-03-07       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.